v3.26.1
Financial Statements (Details) - USD ($)
 3 Months Ended
Mar. 06, 2026
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Financial Statements [Line Items]        
Date of incorporation   Feb. 04, 2015    
Reverse stock split   one for ten    
Working capital surplus   $ 40,216,514    
Accumulated deficit   (59,372,505)   $ (55,789,934)
Net loss   (3,582,571) $ (5,681,353)  
Stock compensation expense   3,144,315 2,379,212  
Depreciation and amortization   $ 323,747 $ 208,882  
Total shares (in Shares)   200,131,535   194,165,141
Aggregate shares of common stock (in Shares)   4,474,833    
Common stock per share (in Dollars per share)   $ 0.0001   $ 0.0001
Directors and Executive Officers [Member]        
Financial Statements [Line Items]        
Shares issued (in Shares)   1,300,006    
Shares price per share (in Dollars per share)   $ 4    
Sold amount   $ 5,197,000    
Chief Executive Officer [Member]        
Financial Statements [Line Items]        
Shares issued (in Shares)   498,753    
Shares price per share (in Dollars per share)   $ 4.01    
Sold amount   $ 2,000,000    
Dr. Frederic Moll Vice Chairman [Member]        
Financial Statements [Line Items]        
Shares issued (in Shares)   501,253    
Shares price per share (in Dollars per share)   $ 3.99    
Sold amount   $ 2,000,000    
Tim Adams Director [Member]        
Financial Statements [Line Items]        
Shares issued (in Shares)   300,000    
Shares price per share (in Dollars per share)   $ 3.99    
Sold amount   $ 1,197,000    
Manipal Global Health Services [Member]        
Financial Statements [Line Items]        
Stock issuance cost   $ 13,424,498    
Common Stock [Member]        
Financial Statements [Line Items]        
Generating gross proceeds $ 18,446,498      
Common Stock [Member]        
Financial Statements [Line Items]        
Total shares (in Shares)   5,774,839    
Common stock per share (in Dollars per share)   $ 3